查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1159343

醣化血红素和C肽的全球市场(2022年～2028年)

Glycosylated Hemoglobin And C Peptide Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

全球醣化血红素和C肽的市场规模在预测期间内预计将以相当的年复合成长率扩大。由于全球糖尿病患病率增加、老年人口增加、製药和生物製药领域的进步以及对 C 肽和糖化血红蛋白的持续研究等几个新兴趋势，预计该市场将增长。但是如果患者患有其他疾病，可能会影响产品的结果，并且测试有时可能会不准确，这可能会限制市场增长。

本报告提供全球醣化血红素和C肽市场相关调查，提供市场概要，以及竞争情形，各市场区隔的市场，各地区分析，及企业简介等资讯。

目录

第1章 报告概要

第2章 市场概要与考察

  • 调查范围
  • 分析师的考察和目前市场趋势

第3章 竞争情形

  • Pfizer Inc.
  • Medtronic Plc
  • F.Hoffmann-La Roche Ltd
  • Sandoz International GmbH
  • Biocon Ltd.
  • 主要策略分析
  • COVID-19对主要企业带来的影响

第4章 市场区隔

  • 全球醣化血红素和C肽市场:各产品
    • 锭剂
    • 胶囊
    • 注射
    • 其他
  • 全球醣化血红素和C肽市场:各用途
    • 肿瘤
    • 血液疾病
    • 糖尿病
    • 其他

第5章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 全球其他地区

第6章 企业简介

  • Novartis AG
  • Sanofi SA
  • Dr Reddy's Laboratories Ltd.
  • Celltrion Healthcare Co. Ltd.
  • Medtronic PLC
  • Lee BioSolution
  • Portea Medical
Product Code: OMR2026466

Global Glycosylated Hemoglobin And C Peptide Market Size, Share & Trends Analysis Report By Type (Tablet, Chewable, And Injectable), And By Application (Oncology, Blood Disorder And Other) Forecast 2022-2028

The global glycosylated hemoglobin and c peptide market is anticipated to grow at a considerable CAGR during the forecast period. The market is expected to grow with some emerging trends which includes increasing prevalence of diabetes across the globe and growing geriatric population, growing advancements in pharmaceutical and biopharmaceutical sectors and on-going research on C-peptide and glycosylated hemoglobin. However, these tests are sometimes less accurate if the patient is dealing with other diseases this may affect the outcome of the product, hence can be a restrain for the market growth.

The global glycosylated hemoglobin and c peptide market is segmented based on product and application. Based on product, the market is segmented into a tablet, capsules, injectable, and others. Based on application the market is sub-segmented into oncology, blood disorder, diabetes, and others. Among these, the blood disorder segment is anticipated to grow at a widespread rate during the forecast period . Blood disorders are increasing in many parts of the world. According to WHO, in the world, around 42% of children whose age is less than 5 years and around 40 % of pregnant women in the world are suffering from anemia. For instance, in Oct 2021, a Nutritionist at the International crop research institute for the semi-arid tropics have suggested that the use of millets can improve hemoglobin and serum levels can reduce anemia.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia-Pacific is going to be a good market for glycosylated hemoglobin and c peptide during the forecasted period. As per the international agency on cancer research, there are around 241,270 patients of non-Hodgkin lymphoma in Asia in the year 2020. For instance, in June 2021, Genentech has announced new data insights on Policy which will be used in Non-Hodgkin lymphoma.

The major companies serving the global glycosylated hemoglobin and c peptide market include Pfizer Inc., Medtronic, F.Hoffmann-La Roche Ltd., Sandoz International GmBh, Biocon Ltd., and others. The market players are adopting different market strategies such as mergers and acquisitions, new product launches, business expansion, partnership collaboration, and others.

Research Methodology

The market study of the global Glycosylated hemoglobin and c peptide market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Glycosylated hemoglobin and c peptide Market Research and Analysis by Product.

2. Global Glycosylated hemoglobin and c peptide Market Research and Analysis by Application.

The Report Covers:

  • Comprehensive Research Methodology of the global Glycosylated hemoglobin and c peptide market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Glycosylated hemoglobin and c peptide Market.
  • Insights about market determinants that are stimulating the global Glycosylated hemoglobin and c peptide market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Glycosylated hemoglobin and c peptides Market
  • Recovery Scenario of Global Glycosylated hemoglobin and c peptides Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Pfizer Inc.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Medtronic Plc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. F.Hoffmann-La Roche Ltd
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Sandoz International GmbH
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Biocon Ltd.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Glycosylated hemoglobin and c peptides Market by Product
    • 4.1.1. Tablet
    • 4.1.2. Capsules
    • 4.1.3. Injectable
    • 4.1.4. Others
  • 4.2. Global Glycosylated hemoglobin and c peptides Market by Application
    • 4.2.1. Oncology
    • 4.2.2. Blood disorder
    • 4.2.3. Diabetes
    • 4.2.4. Other

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Novartis AG
  • 6.2. Sanofi SA
  • 6.3. Dr Reddy's Laboratories Ltd.
  • 6.4. Celltrion Healthcare Co. Ltd.
  • 6.5. Medtronic PLC
  • 6.6. Lee BioSolution
  • 6.7. Portea Medical

LIST OF TABLES

  • 1. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 2. GLOBAL TABLET IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL CAPSULES IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL INJECTABLE IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL OTHER GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 7. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN BLOOD DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 15. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 17. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS PRODUCT, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET, 2021-2027 (%)
  • 4. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
  • 5. GLOBAL TABLET IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL CAPSULES IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL INJECTABLE IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL OTHER GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE PRODUCT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 10. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN ONCOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN BLOOD DISORDER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN DIABETES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN OTHER APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. US GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. CANADA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. UK GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. FRANCE GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. GERMANY GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. ITALY GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF EUROPE GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. INDIA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. CHINA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. JAPAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SOUTH KOREA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)